The US Food and Drug Administration is planning to update some of its contact lens and lens solution testing and labeling standards in an effort among other things to prevent potential eye infections related to the products. The FDA will seek input on its plans from its ophthalmic device advisory panel on 13 May1,2.
The changes include a recommendation for more “real-world” testing parameters. The discussion will include topics such as microbiological and chemical pre-clinical testing, revision of pre-clinical test requirements to address...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?